About Clinical Trials and Therapeutic
Clinical Trials and Therapeutic MJCTT is a vibrant, international, peer-reviewed journal committed to advancing evidence-based innovations in clinical trials and therapeutics. The journal welcomes high-impact research across all trial phases and therapeutic approaches, promoting open-access excellence for global healthcare progress.
Aim and Scope
MJCTT publishes peer-reviewed, open-access research spanning innovative clinical trials, therapeutic breakthroughs, and real-world evidence. Submit protocols, translational studies, and trial design research across cutting-edge medical fields including oncology, rare diseases, precision medicine, and more.
The Mogito Open Access Journal of Clinical Trials & Therapeutics (MJCTT) invites bold, high-quality submissions that push the boundaries of modern medical science. We welcome:
- Original clinical trial reports
- Study protocols and innovative trial designs
- Therapeutic analyses and translational breakthroughs
- Real-world evidence and post-market surveillance
- Meta-research in regulatory science and ethics
Key focus areas include:
- Pharmacologic & Biologic Therapies
- Medical Devices & Digital Therapeutics
- Oncology & Immunotherapy Trials
- Infectious Disease & Vaccine Development
- Rare Disease & Orphan Drug Innovation
- Psychiatric & Neurological Therapeutics
- Global & Community-Based Research Models
- Precision & Personalized Medicine
- Pharmacovigilance & Post-marketing Monitoring
- Adaptive & Pragmatic Trial Methodologies
Join MJCTT in reshaping the landscape of clinical research—open, ethical, and globally accessible.
Open Access, Licensing & Ethics
MJCTT is published under the Creative Commons Attribution License (CC BY 4.0), ensuring that all content is freely available to the public, while authors retain full copyright. We strictly adhere to ICMJE, CONSORT, and COPE guidelines.
What makes MJCM different?
- We champion clinical applicability over theoretical complexity.
- We value equity and accessibility, inviting research from both high-income and under-resourced settings.
- We engage in constructive, timely, and fair peer review that fosters mentorship and scholarly growth.
- We seek to close the research-to-practice gap, especially in fast-evolving health landscapes.
Partner with MJCTT
Whether you’re pioneering a first-in-human therapeutic, leading a multicenter global trial, or redefining how clinical outcomes are evaluated—your expertise is needed.
At MJCTT, we invite researchers, clinicians, and innovators to:
- 🖊️ Submit original manuscripts that advance therapeutic knowledge
- 🧠 Join our editorial board or peer review panel to shape global research standards
- 🤝 Collaborate with a forward-thinking community committed to open access and ethical science
Together, we can accelerate the translation of evidence into life-changing therapies—and ensure that clinical research remains transparent, inclusive, and impactful.
📬 Submit your manuscript: [mjctt@mogitojournals.org]
📩 Contact our editorial team: editors_mjctt@mogitojournals.org
Our Mission
Transforming Clinical Trials into Global Therapeutic Impact
MJCTT is on a mission to revolutionize clinical trial communication by promoting ethical, transparent, and globally inclusive research. We amplify underrepresented voices and ensure life-saving therapies are freely accessible to all.
At the Mogito Open Access Journal of Clinical Trials & Therapeutics (MJCTT), our mission is to revolutionize the way clinical trials are shared, interpreted, and accessed. We recognize that therapeutic innovation unfolds not only in laboratories, but also through policy reforms, clinical practice, and meaningful patient partnerships.
Our core goals are to:
- 🔍 Advance transparency, reproducibility, and ethical integrity in every stage of research
- 🌍 Empower scientists and clinicians in low- and middle-income regions to shape global therapeutic conversations
- 🚀 Accelerate open access to life-altering treatments, ensuring evidence reaches practitioners, patients, and policymakers without delay or paywalls
By breaking traditional barriers in scholarly communication, MJCTT champions a new era of accessible, impactful, and collaborative therapeutic science.
Our Editorial Vision
At Mogito Open Access Journal of Clinical Trials & Therapeutics (MJCTT), our editorial direction is guided by a diverse global team of clinician-scientists, statisticians, ethicists, and policy leaders. Together, we are united by a shared commitment to reshape the way clinical evidence is created, reviewed, and disseminated.
Our editorial mission is to:
- ✅ Uphold rigorous peer review and radical transparency in clinical research
- ✅ Promote multidisciplinary, patient-engaged, and ethically grounded studies
- ✅ Support early-career investigators and underrepresented research teams
- ✅ Highlight novel trial methodologies and disruptive therapeutic strategies
What makes MJCTT truly distinct is our dedication to publishing not only outcomes, but also:
- 📄 Trial protocols and design rationales
- ❌ Negative results and failed trials, often overlooked but deeply valuable
- 📝 Pre-registrations and open peer-review reports, supporting reproducibility
Through this inclusive and forward-thinking editorial vision, MJCTT empowers researchers to share the full spectrum of clinical inquiry, fostering a richer, more reliable scientific record.
Indexing & Visibility (Coming Soon)
MJCTT is working toward inclusion in DOAJ, PubMed Central, Scopus, and Google Scholar, ensuring our authors’ work is discoverable, citable, and widely disseminated..
Call for Editorial Board Members, Reviewers, and Manuscript Submissions for Mogito Open Access Journals of Clinical Trials and Therapeutic
Mogito Open Access Journal of Clinical Trials & Therapeutics (MJCTT) is calling on passionate and qualified professionals to help shape a transformative, inclusive, and globally visible platform for clinical research and therapeutic advancement.
We are currently welcoming applications and contributions in the following roles:
🟠 Editorial Board Members
Researchers, trial investigators, and therapeutic experts with experience across any area of clinical trials or pharmacological science are invited to guide MJCTT’s editorial mission, ensure scientific rigor, and support ethical, transparent peer review.
🟠 Peer Reviewers
Qualified professionals with a commitment to methodological integrity and constructive feedback are encouraged to join our reviewer network and uphold high standards of academic excellence.
🟠 Manuscript Contributors
MJCTT actively seeks original research articles, study protocols, therapeutic evaluations, real-world evidence reports, and meta-analyses. Submissions in multiple languages are welcome, and we especially highlight inclusive, global contributions to science.
Whether you’re a senior scholar or an emerging researcher, MJCTT offers a unique opportunity to elevate your work, connect with a global community, and champion open-access clinical science.
👉 Get involved today—help drive innovation in clinical trials and therapeutics.
📩 Contact us at: [editor_mjctt@mogitojournals.org]
To celebrate the launch of MJCM, the first 10 accepted manuscripts will be published free of charge.
Submit now and enjoy open access publishing at no cost.
👉 editors_mjctt@mogitojournals.org
Ready to Publish Your Research
We’re here to guide you through every step of your publishing journey—from submission to global reach..
Let’s advance knowledge and discovery—together.
When connected with us, you aren’t growing your business alone. We have your back and put in our best to contribute to the growth of your entire team and organization. So, if you are “When you publish with us, you’re not navigating the process alone. Our editorial team is committed to supporting you through peer review, publication, and global dissemination. If you’re looking for the right platform to share your research, enhance visibility, and make a meaningful impact—Mogito is here for you.”
“We are passionate about scholarly publishing and committed to helping researchers share their work with the world. As your trusted publishing partner, we ensure a seamless, transparent, and supportive process from submission to publication.”
